We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

200 hedge funds and large institutions have $975M invested in ANI Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 22

28% more capital invested

Capital invested by funds: $764M → $975M (+$212M)

19% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 54

10% more funds holding

Funds holding: 182 → 200 (+18)

0.81% less ownership

Funds ownership: 67.78% → 66.98% (-0.81%)

91% less call options, than puts

Call options by funds: $3.41M | Put options by funds: $39.2M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
200
Holders Change
+18
Holders Change %
+9.89%
% of All Funds
2.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
64
Reduced
54
Closed
22
Calls
$3.41M
Puts
$39.2M
Net Calls
-$35.8M
Net Calls Change
-$36.9M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$13.4M
2
TCM
Tang Capital Management
California
+$9.06M
3
SCM
Sio Capital Management
New York
+$5.27M
4
N
Nuveen
North Carolina
+$5.24M
5
Invesco
Invesco
Georgia
+$3.96M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$12.8M
2
GACM
Global Alpha Capital Management
Quebec, Canada
-$11.6M
3
RCMNY
Rubric Capital Management (New York)
New York
-$10M
4
SC
Stempoint Capital
New York
-$4.71M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCG
51
Lisanti Capital Growth
New York
$2.22M +$1.94M +32,085 New
HSA
52
Hussman Strategic Advisors
Maryland
$2.18M +$1.9M +31,500 New
CS
53
Credit Suisse
Switzerland
$2.17M – – –
Public Sector Pension Investment Board (PSP Investments)
54
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.16M – – –
Los Angeles Capital Management
55
Los Angeles Capital Management
California
$1.73M +$326K +5,408 +28%
New York State Teachers Retirement System (NYSTRS)
56
New York State Teachers Retirement System (NYSTRS)
New York
$1.64M +$81.3K +1,346 +6%
DekaBank Deutsche Girozentrale
57
DekaBank Deutsche Girozentrale
Germany
$1.57M – – –
Allspring Global Investments
58
Allspring Global Investments
North Carolina
$1.47M +$953K +15,790 +288%
Millennium Management
59
Millennium Management
New York
$1.44M -$90.1K -1,493 -7%
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$1.43M +$647K +10,716 +107%
Brown Advisory
61
Brown Advisory
Maryland
$1.28M – – –
MAM
62
Martingale Asset Management
Massachusetts
$1.27M +$85.2K +1,411 +8%
Citigroup
63
Citigroup
New York
$1.26M +$234K +3,881 +27%
UBS Group
64
UBS Group
Switzerland
$1.21M -$94.7K -1,569 -8%
FDCDDQ
65
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.17M – – –
Prudential Financial
66
Prudential Financial
New Jersey
$1.15M -$43.2K -715 -4%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$1.12M +$14.1K +233 +1%
AllianceBernstein
68
AllianceBernstein
Tennessee
$1.1M +$98.4K +1,630 +11%
UBS AM
69
UBS AM
Illinois
$1.07M – – –
Connor, Clark & Lunn Investment Management (CC&L)
70
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.06M +$415K +6,867 +81%
SGI
71
Summit Global Investments
Utah
$1.05M +$67.3K +1,115 +8%
JCIA
72
Jackson Creek Investment Advisors
Colorado
$1.03M -$1.75K -29 -0.2%
Allianz Asset Management
73
Allianz Asset Management
Germany
$1.03M +$199K +3,300 +28%
Barclays
74
Barclays
United Kingdom
$1.03M -$627K -10,383 -41%
WAM
75
Wakefield Asset Management
Colorado
$979K +$855K +14,163 New
1 2
3
4 5

ANIP Hedge Fund Activity: Q1 2024 in Review

200 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2024, worth a combined $975M — up 28% from $764M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ANIP positions and 22 closed out — a net gain of 19 holders — while 64 added to existing stakes and 54 trimmed.

The largest buyer was Deep Track Capital, adding an estimated $13.4M. The largest seller was Morgan Stanley, cutting an estimated $12.8M.

  • 200 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2024, up from 182 in Q4 2023.
  • Funds reported $975M of ANI Pharmaceuticals stock for Q1 2024, up 28% quarter-over-quarter.
  • 41 funds opened new ANI Pharmaceuticals positions in Q1 2024 and 22 closed out, a net change of +19 holders.
  • The largest ANI Pharmaceuticals buyer in Q1 2024 was Deep Track Capital, an estimated $13.4M added.
  • The largest ANI Pharmaceuticals seller in Q1 2024 was Morgan Stanley, an estimated $12.8M sold.

Based on aggregated 13F filings for Q1 2024.